Executive Director, U.S. Public Policy (CMS, HHS & Payment Policy)

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
 
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. 
 
Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

What You'll Do #LI-TC1

BridgeBio is establishing a dedicated, senior U.S. public policy leadership role focused on CMS, HHS, and coverage and payment policy that directly affects patient access and innovation across the BridgeBio portfolio.

The Executive Director, U.S. Public Policy will own the end-to-end U.S. public policy strategy related to Medicare, Medicaid, and payment models, and will be accountable for shaping policy positions that influence access, reimbursement, and long-term portfolio value, and advising on implementation internally.

This role operates at the enterprise level, advising executive leadership, shaping portfolio strategy, and serving as BridgeBio’s primary public policy authority with U.S. regulators.

Responsibilities

Lead U.S. public policy strategy

• Define and lead BridgeBio’s U.S. public policy strategy, particularly Medicare (Parts B and D), Medicaid, alternative and value-based payment models, IRA implementation, CMMI initiatives, and coverage and reimbursement policy
• Serve as the company’s internal expert on U.S. public policy, advising leadership on policy design, implementation risk, and long-term implications
• Translate complex public policy developments into clear strategic options and recommendations for executive leadership

CMS, HHS, and external engagement leadership

• Act as BridgeBio’s primary interface with CMS and HHS, engaging directly with agency leadership, career staff, and relevant HHS offices
• Bring and leverage an extensive existing network across CMS and HHS to inform strategy and anticipate policy direction
• Represent BridgeBio externally in public policy coalitions, trade associations, and forums where coverage, payment, and access policy are central

Analytical leadership and policy modeling